REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.50
Bid: 40.00
Ask: 43.00
Change: 0.50 (1.22%)
Spread: 3.00 (7.50%)
Open: 41.50
High: 41.50
Low: 41.50
Prev. Close: 41.00
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio news - FIPP increases stake in Celerum

12 Feb 2020 07:00

RNS Number : 6770C
Frontier IP Group plc
12 February 2020
 

RNS Reach

AIM: FIPP

12 February 2020

 

Frontier IP Group plc

("Frontier IP" or the "Group")

 

Portfolio news - Frontier IP raises stake in real-time, nature-inspired Artificial Intelligence ("AI") company Celerum to 33.8 per cent

Frontier IP, a specialist in commercialising intellectual property, has raised its equity stake in portfolio company Celerum Limited ("Celerum" or the "Company") from 10 per cent to 33.8 per cent. The increase is in return for an investment of £25,000, converting a previous loan of £21,818 into equity, and for providing £50,000 worth of additional strategic, business and hands-on software development services.

Celerum, a spin out from Robert Gordon University ("RGU"), Aberdeen, is developing novel artificial intelligence to help businesses improve the operational efficiency of logistics and supply chains. It also has the potential to tackle a host of other complex scientific, engineering and industrial challenges. Frontier IP is stepping up its support for the Company in response to increased industry interest.

As well as helping organisations improve their advanced planning and scheduling, the software works in real time, allowing them to respond immediately in the most effective way to unforeseen circumstances. For example, if an accident blocks a road, the software will immediately work out the most efficient alternative routes to redirect lorries, automatically accounting for the knock-on effects on the rest of a fleet, perhaps by rescheduling other deliveries.

The Company's approach has been proven in a number of projects undertaken by founder Professor John McCall, Head of the School of Computing, Science and Digital Media at RGU. They include a knowledge transfer partnership, backed by Innovate UK, with one of Scotland's biggest privately-owned hauliers ARR Craib to maximise vehicle use and fleet effectiveness.

Professor McCall has more than 25 years research experience in nature-inspired computing ("NIC"). NIC looks to develop new software and AI algorithms based on natural processes and behaviours. Ant colonies, for example, are extremely effective at finding the most efficient routes to find food; NIC digitally mimics how they do so to solve human supply chain and logistical issues, for instance.

Other examples include particle swarm optimisation, based on how birds and fish behave in flocks and schools, and genetic algorithms, software techniques based on natural selection and evolutionary genetics.

Celerum was incorporated in 2013 to develop and commercialise Professor McCall's work. Since then, grant funding to his research group at RGU has totalled £2,336,814 from 23 grants, including £964,649 from six Innovate UK grants.

ARR Craib Chief Operating Officer Mike Simpson said: "We've been working with Professor McCall and his research group at RGU for five years. We're delighted with the significant benefits their work has delivered for us in improving visibility of the population of work to be covered. This covers a number of different work streams in an extremely dynamic environment, and, most importantly, includes improved planning and fleet productivity. We're pleased to continue to work with Professor McCall as we seek to maximise the benefits of their work on optimisation technologies."

 Celerum founder and Head of the School of Computing Science and Digital Media at RGU Professor John McCall said: "This new investment and support from Frontier will allow us to take advantage of the strong interest shown in our optimisation technologies across a range of industries, taking it beyond logistics and supply chains to help improve operational efficiency, reduce costs and streamline processes in a number of sectors."

Frontier IP Chief Executive Officer Neil Crabb said: "We are delighted to increase our equity stake in Celerum. The Company's artificial intelligence has already proved its worth with industry, and clearly has enormous potential to improve efficiency within the transport services and logistics sector, and benefit many other industries."

ENQUIRIES

Frontier IP Group plc

T: 020 7332 2338

Neil Crabb, Chief Executive

Andrew Johnson, Communications & Investor Relations

Group website: www.frontierip.co.uk

 

M: 07464 546 025

Allenby Capital Limited (Nominated Adviser)

T: 0203 328 5656

Nick Athanas / Nicholas Chambers

 

ABOUT FRONTIER IP

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

 

About RNS Reach Announcements

This is an RNS Reach announcement. RNS Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAQFLFFBLLLBBX
Date   Source Headline
7th May 202410:15 amRNSTVG to collaborate with The Pirbright Institute
2nd May 20247:00 amRNSFrontier IP announces stake in DiaGen
17th Apr 20241:59 pmRNSHolding(s) in Company
12th Apr 20247:00 amRNSAppointment of Chief Financial Officer
2nd Apr 202412:44 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSUnaudited Half Year Results
4th Mar 20241:40 pmRNSHolding(s) in Company
29th Feb 20243:12 pmRNSSale of shares in Exscientia
30th Jan 202411:45 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSOctopus invest in Alusid as part of equity funding
29th Dec 202312:00 pmRNSTotal Voting Rights
19th Dec 20234:46 pmRNSHolding(s) in Company
15th Dec 20236:12 pmRNSReplacement - Result of AGM and Directorate Change
15th Dec 20232:07 pmRNSResult of AGM and Directorate Change
13th Dec 20237:00 amRNSPortfolio news - The Vaccine Group
11th Dec 20237:00 amRNSHolding(s) in Company
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholdings
28th Nov 20237:00 amRNSBoard Change
21st Nov 20237:00 amRNSPosting of Annual Report and Notice of AGM
9th Nov 20235:27 pmRNSHolding(s) in Company
3rd Nov 20237:05 amRNSGrant of options
1st Nov 20235:48 pmRNSExercise of Options & PDMR Shareholdings & TVR
31st Oct 20237:01 amRNSBoard changes
31st Oct 20237:00 amRNSFinal results for the year ended 30 June 2023
23rd Oct 20237:00 amRNSNew portfolio company Deakin Bio-Hybrid Materials
12th Oct 20232:05 pmRNSHolding(s) in Company
21st Sep 20237:00 amRNSExscientia announces collaboration with Merck
14th Sep 20235:21 pmRNSHolding(s) in Company
14th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
11th Sep 20237:00 amRNSPortfolio news – Pulsiv appoints Chairman and CPO
8th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
10th Aug 20238:45 amRNSPortfolio news – Fieldwork Robotics
24th Jul 20237:00 amRNSPortfolio news – CamGraPhIC loan facility
20th Jul 20235:18 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSSale of shares in Exscientia
26th May 20236:06 pmRNSHolding(s) in Company
9th May 20237:00 amRNSTopps Tiles launches first Alusid made tile range
21st Apr 20234:00 pmRNSDirectorate Change
20th Apr 20235:26 pmRNSHolding(s) in Company
27th Mar 20235:17 pmRNSHolding(s) in Company
17th Mar 20232:46 pmRNSGrant of options
15th Mar 20237:00 amRNSBoard changes
15th Mar 20237:00 amRNSUnaudited Half Year Results
30th Jan 20237:00 amRNSAlusid in collaboration with Imerys
9th Jan 20237:00 amRNSCelerum appoints David Gladding as CEO
9th Dec 20224:08 pmRNSResult of AGM
7th Dec 20221:25 pmEQSThe Vaccine Group completes two deadly disease vaccination projects
6th Dec 20227:00 amRNSFrontier IP to host Portfolio Demo Day
5th Dec 20227:00 amRNSThe Vaccine Group completes Lassa fever project

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.